Exagens

Exagens company information, Employees & Contact Information

Updated May 2026

Quick answer

Exagens is a Software Development company and founded in 2014. It has approximately 17 employees on record. Contact data was last refreshed in May 2026. Find Exagens's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Exagens’ Behavioral Banking solutions enable community-based financial institutions to grow with their members/customers and win against big banks. They have been responsible for improving the financial lives of millions while simultaneously increasing engagement, digital sales, and adoption/usage, thereby improving financial institutions’ top line while delivering operational efficiencies to strengthen the bottom line. Our Behavioral Banking solutions fuse industry-leading behavioral science and data analytics to proactively and emotionally engage people via compelling money-related experiences specific to their unique situation, catalyzing them to save, spend, borrow and invest wisely. As a result, Exagens and its solutions have received multiple industry awards including ones from EFMA, Celero and OCTAS and has been named a Cool Vendor in Banking by Gartner.

Company Details

Employees
17
Founded
-
Address
147 Rue St Paul Ouest, Montréal,quebec H2y1z5,canada
Phone
438-387-4107 xt. 203
Email
ex****@****ens.com
Industry
Software Development
NAICS
Software Publishers
HQ
Montréal, Quebec
Looking for a particular Exagens employee's phone or email?

Exagens Questions

News

Desjardins signs multi-year contract with AI fintech Exagens - FinTech Futures

Desjardins signs multi-year contract with AI fintech Exagens FinTech Futures

Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now (NASDAQ:XGN) - Seeking Alpha

Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now (NASDAQ:XGN) Seeking Alpha

Exagen’s Revenue Rises, But Profit Remains Elusive In Q2 - Finimize

Exagen’s Revenue Rises, But Profit Remains Elusive In Q2 Finimize

The 26% return this week takes Exagen's (NASDAQ:XGN) shareholders one-year gains to 102% - simplywall.st

The 26% return this week takes Exagen's (NASDAQ:XGN) shareholders one-year gains to 102% simplywall.st

Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings Defense World

Top Exagens Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant